Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Der Urologe. Ausg. A|April 24, 2001
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]S H Hautmann, G L Schroeder, F Civantos, et al.
The Journal of Urology|August 1, 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancerM F Sarosdy, R W deVere White, M S Soloway, et al.
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
Cancer|May 15, 1987
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of lifeC A Presant, M S Soloway, S S Klioze, et al.
Cancer|November 15, 1996
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.
Urology|September 25, 1997
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.
Cancer|November 15, 1985
Buserelin as primary therapy in advanced prostatic carcinomaC A Presant, M S Soloway, S S Klioze, et al.
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.
Pageof 24